Capricor Therapeutics to Host Key Opinion Leader Call on the Role of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy (DMD)
Stock Information for Capricor Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.